NBY   $1.95  22.64% Market Closed

NovaBay Pharmaceuticals, Inc.
Total Cash 751.00K
totalCashPerShare 0.154
EBITDA -5.03M
Total Debt 2.01M
quickRatio 0.36
currentRatio 0.624
Total Revenue 13.88M
debtToEquity
Revenue/Share 25.339
ROA -0.32804
ROE -2.8295999
grossProfits
freeCashflow 2.46M
operatingCashflow -3.03M
earningsGrowth
revenueGrowth -0.321
grossMargins 0.57203
ebitdaMargins -0.36236
operatingMargins -0.43875
profitMargins -0.76808
enterpriseValue 4.95M
forwardPE -0.8780953
floatShares 4.88M
sharesOutstanding 4.89M
sharesShort 17.89K
sharesShortPriorMonth 126.67K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.00%
Short Ratio help_outline 0.0
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.462
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -16.68M
trailingEps -76.04%
forwardEps -0.84%
enterpriseToEbitda -0.98
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 3Q 2024
institutionsCount 9
lastUpdated Nov. 6, 2024, 6:24 p.m.